当前位置:首页 - 行情中心 - 花园生物(300401) - 财务分析 - 现金流量表

花园生物

(300401)

  

流通市值:63.36亿  总市值:64.40亿
流通股本:5.36亿   总股本:5.45亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,057,655,205.69711,214,425.96388,208,771.21,185,950,232.88
  收到的税费返还66,707,989.7643,797,898.228,322,989.3566,938,587.44
  收到其他与经营活动有关的现金92,514,815.759,700,250.3526,658,872.79127,380,712.85
  经营活动现金流入小计1,216,878,011.15814,712,574.51443,190,633.341,380,269,533.17
  购买商品、接受劳务支付的现金511,396,285.04335,409,505.6281,901,769.01384,748,158.71
  支付给职工以及为职工支付的现金138,883,617.93101,114,436.0564,177,936.6155,619,626.26
  支付的各项税费102,880,682.880,256,043.0847,474,482.71118,449,738.67
  支付其他与经营活动有关的现金148,238,474.33103,212,242.8750,018,483.64246,713,755.75
  经营活动现金流出小计901,399,060.1619,992,227.62243,572,671.96905,531,279.39
  经营活动产生的现金流量净额315,478,951.05194,720,346.89199,617,961.38474,738,253.78
二、投资活动产生的现金流量:
  收回投资收到的现金1,620,000,0001,320,000,000570,000,0001,495,000,000
  取得投资收益收到的现金4,218,117.83,677,405.482,048,126.034,197,423.2
  处置固定资产、无形资产和其他长期资产收回的现金净额315,72780,800-933,089.99
  投资活动现金流入小计1,624,533,844.81,323,758,205.48572,048,126.031,500,130,513.19
  购建固定资产、无形资产和其他长期资产支付的现金252,390,346.24148,852,026.69108,211,729.94361,956,910.67
  投资支付的现金1,410,000,0001,020,000,000390,000,0001,748,331,606
  投资活动现金流出小计1,662,390,346.241,168,852,026.69498,211,729.942,110,288,516.67
  投资活动产生的现金流量净额-37,856,501.44154,906,178.7973,836,396.09-610,158,003.48
三、筹资活动产生的现金流量:
  取得借款收到的现金519,000,000439,000,000330,000,0001,127,100,000
  收到其他与筹资活动有关的现金90,000,00090,000,000-118,810,936.95
  筹资活动现金流入小计609,000,000529,000,000330,000,0001,245,910,936.95
  偿还债务支付的现金407,000,000357,000,00090,000,0001,153,200,278.51
  分配股利、利润或偿付利息支付的现金121,163,769.7384,969,909.0417,686,978.2992,150,776.76
  支付其他与筹资活动有关的现金---208,810,936.95
  筹资活动现金流出小计528,163,769.73441,969,909.04107,686,978.291,454,161,992.22
  筹资活动产生的现金流量净额80,836,230.2787,030,090.96222,313,021.71-208,251,055.27
四、汇率变动对现金及现金等价物的影响-11,351,145.83-7,830,291.98-5,049,399.53532,666.51
五、现金及现金等价物净增加额347,107,534.05428,826,324.66490,717,979.65-343,138,138.46
  加:期初现金及现金等价物余额924,323,660.11924,323,660.11924,323,660.111,267,461,798.57
  期末现金及现金等价物余额1,271,431,194.161,353,149,984.771,415,041,639.76924,323,660.11
补充资料:
  净利润-131,920,754.06-304,858,290.96
  资产减值准备-30,511.32-6,963,915.27
  固定资产和投资性房地产折旧-87,886,600.84-169,845,830.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-87,886,600.84-169,845,830.56
  无形资产摊销-4,997,903.92-8,500,839.84
  处置固定资产、无形资产和其他长期资产的损失--52,073.26-2,239,186.79
  固定资产报废损失-12,010.78-1,689,224.11
  公允价值变动损失--458,657.53--3,769,473.98
  财务费用-27,473,845.95-31,936,570.53
  投资损失--827,921.78--1,405,551.96
  递延所得税--9,482,636.33-3,060,612.69
  其中:递延所得税资产减少--9,972,969.93-635,944.49
    递延所得税负债增加-490,333.6-2,424,668.2
  存货的减少-10,539,829.58-86,143,302.39
  经营性应收项目的减少--26,554,903.79--132,185,672.44
  经营性应付项目的增加--30,835,277.58--8,037,686.36
  其他---2,256,392.67
  现金的期末余额-1,353,149,984.77-924,323,660.11
  减:现金的期初余额-924,323,660.11-1,267,461,798.57
  现金及现金等价物的净增加额-428,826,324.66--343,138,138.46
公告日期2026-10-202026-08-152026-04-182026-04-18
审计意见(境内)标准无保留意见
TOP↑